col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


116 Results       Page 1

 [1] 
Ovid: AIDS
  original article Date Title Authors   All Authors
1 [GO] 2025―May―08 Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection Sabrina Marozin, Valeria Bono, Martina Mazzoccoli, Matteo Augello, Roberta Rovito, Lucia Taramasso, et al. (+6)
2 [GO] 2025―Apr―25 Outcomes of children living with HIV during the COVID-19 pandemic in Vietnam Dewi K. Wati, Lam V. Nguyen, Du T. Quy, Dinh Q. Nguyen, Oanh N. Le, Azar Kariminia
3 [GO] 2025―Mar―13 SARS-CoV-2 antibody prevalence in adults living with HIV Mary Lucey, Fiona Burns, Sanjay Bhagani, Marc Lipman, Sara Madge, Margaret Johnson, et al. (+4)
4 [GO] 2025―Jan―29 Contextual factors related to the overlap of the overdose and HIV pandemics and their clinical implications Karl Goodkin, Harold A. Pollack
5 [GO] 2024―Dec―30 The challenge of normalizing vaccine behaviors in the postpandemic era Christina Wiesmann, Brian Conway
6 [GO] 2024―Nov―29 Assessing COVID-19 pandemic impacts on the health of PWID using a novel data sharing model Heather Bradley, Nicole Luisi, Anastasia Carter, Terri D. Pigott, Daniela Abramovitz, Sean T. Allen, et al. (+38)
7 [GO] 2024―Nov―22 SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa Emmanuelle Papot, Tamara TOVAR-SANCHEZ, Joana WOODS, Guillaume Thaurignac, Nnakelu Eriobu, Margaret Borok, et al. (+19)
8 [GO] 2024―Nov―14 Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes Louise Bering, Line Dam Heftdal, Safura-Luise Heidari, Sebastian Rask Hamm, Cecillie Bo Hansen, Dina Leth Møller, et al. (+18)
9 [GO] 2024―Nov―05 Medical mistrust and vaccine-hesitant attitudes explain SARS-CoV-2 vaccination disparities in a mixed-serostatus cohort M. Reuel Friedman, Gina Wingood, Kristen D. Krause, Sarah Krier, Gypsyamber D'souza, Mirjam-Colette Kempf, et al. (+12)
10 [GO] 2024―Oct―30 Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV Matteo Augello, Valeria Bono, Roberta Rovito, Andrea Santoro, Camilla Tincati, Giulia Marchetti
11 [GO] 2024―Aug―29 Impact of COVID-19 vaccination on HIV parameters in people with HIV on antiretroviral therapy Tiurlina Siregar, Rebeka Konstantina Weriditi, Yansen Alberth Reba, M. Zaenul Muttaqin, Yovian Yustiko Prasetya
12 [GO] 2024―Jul―11 Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves Catharine Chambers, Curtis L. Cooper, Abigail E. Kroch, Sarah A. Buchan, Claire E. Kendall, Jeffrey C. Kwong, et al. (+18)
13 [GO] 2024―May―30 Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV: Erratum
14 [GO] 2024―May―24 Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands Marlou J. Jongkees, Ngoc H. Tan, Daryl Geers, Rory D. de Vries, Corine H. Geurtsvankessel, Kathryn S. Hensley, et al. (+11)
15 [GO] 2024―Apr―05 Vespers: A nursing origin story set in the dawn of the HIV pandemic Emily Anne Barr
16 [GO] 2024―Jan―15 Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size Maggie C. Duncan, F. Harrison Omondi, Natalie N. Kinloch, Hope R. Lapointe, Sarah Speckmaier, Nadia Moran-Garcia, et al. (+14)
17 [GO] 2024―Jan―09 How the COVID-19 pandemic and the health system's response reduced HIV testing and increased late diagnoses in Mexico Fernando Macías-González, Heleen Vermandere, Alicia Piñeirúa-Menendez, Sergio Bautista-Arredondo
18 [GO] 2024―Jan―03 The association of Changes In Depression Severity After The Onset of The Covid-19 Pandemic and Viral Non-Suppression Among People With HIV Tarfa Verinumbe, Catherine R. Lesko, Richard D. Moore, Anthony T. Fojo, Jeanne Keruly, LaQuita N. Snow, et al. (+4)
19 [GO] 2023―Nov―21 Individuals with HIV Are Likely Targets for Long COVID Iulia Filip
20 [GO] 2023―Nov―15 False-positive HIV screening tests during the COVID-19 pandemic, a passing trend? Rinat Lasmanovich, Dor Atias, Orna Mor, Uri Obolski
21 [GO] 2023―Nov―08 Impact of COVID-19-related clinic closures on HIV incidence in a multicentre study of young adult MSM and transgender women in Kenya Elizabeth Wahome, Fredrick O. Otieno, Joshua Kimani, Anders Boyd, Duncan Okall, Joseph Nzioka, et al. (+6)
22 [GO] 2023―Oct―13 Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1 Frédérique Chammartin, Alexandra Griessbach, Katharina Kusejko, Annette Audigé, Selina Epp, Marcel P. Stoeckle, et al. (+12)
23 [GO] 2023―Aug―30 Outcomes of coronavirus disease 2019-related hospitalization among people with HIV: historical cohort from the Greater Paris area multicenter hospital data warehouse Valérie Pourcher, Florence Tubach, Antoine Rozes, Samia Boussouar, Candice Estellat
24 [GO] 2023―Aug―03 More evidence for inequitable COVID-19 outcomes in people with HIV Laura Waters, Ian Woolley
25 [GO] 2023―Aug―03 Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328) Cecilia T. Costiniuk, Joel Singer, Terry Lee, Yannick Galipeau, Pauline S. McCluskie, Corey Arnold, et al. (+24)
26 [GO] 2023―Jul―14 Antibody and T-cell responses elicited by coronavirus disease 2019 vaccination in people with HIV-1: the case of late presenters Ali Ahmad, Suzanne Samarani, Cecilia T. Costiniuk
27 [GO] 2023―Jul―14 Incidence and severity of SARS-CoV-2 infection in children and young people with HIV in Europe
28 [GO] 2023―Jul―03 Preventing SARS-CoV-2 infection and its severe outcomes in HIV-infected people Nicola Abrescia
29 [GO] 2023―Jul―03 No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands Myrthe L. Verburgh, Marc van der Valk, Bart J.A. Rijnders, Peter Reiss, Ferdinand W.N.M. Wit
30 [GO] 2023―Jun―01 Presence of the M184I mutation after short-term exposure to azvudine for COVID-19 in people living with HIV Rui Jiang, Jianjun Sun, Bihe Zhao, Renfang Zhang, Li Liu, Jun Chen
31 [GO] 2023―May―18 COVID-19 in people with HIV in the Netherlands, the ATHENA cohort study Ferdinand WNM Wit, Peter Reiss, Bart Rijnders, Casper Rokx, Anna Roukens, Kees Brinkman, Marc van der Valk
32 [GO] 2023―May―18 Six-month immune responses to mRNA-1273 Vaccine in cART-treated late presenter people living with HIV according to previous SARS-CoV-2 Infection Matteo Augello, Valeria Bono, Roberta Rovito, Camilla Tincati, Antonella D’arminio Monforte, Giulia Marchetti
33 [GO] 2023―May―17 Cognitive concerns are a risk factor for mortality in people with human immunodeficiency virus and COVID-19 Douglas R. Wilcox, Emily A. Rudmann, Elissa Ye, Ayush Noori, Colin Magdamo, Aayushee Jain, et al. (+7)
34 [GO] 2023―Apr―18 Immunogenicity, effectiveness and safety of SARS-CoV-2 vaccination in people living with HIV: A systematic review and meta-analysis David WJ Griffin, Rekha Pai Mangalore, Jennifer F Hoy, James H Mcmahon
35 [GO] 2023―Mar―15 Effectiveness of COVID-19 primary and booster vaccination in HIV-infected individuals Bin Su, Guido Vanham
36 [GO] 2023―Feb―15 SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive ART Peter K. Cheung, Hope R. Lapointe, Yurou Sang, Siobhan Ennis, Francis Mwimanzi, Sarah Speckmaier, et al. (+10)
37 [GO] 2023―Feb―13 Increased risk of false positive HIV ELISA results after COVID-19 Laura G. Alfie, Yesica S. Longueira, Mónica Pippo, Leonel Cruces, María F. Quiroga, Gabriela Turk, Natalia Laufer
38 [GO] 2023―Feb―13 An estimate of excess deaths among people with HIV during the COVID-19 pandemic in the United States, 2020 Weiming Zhu, Ya-lin A. Huang, Ruiguang Song, Jeffrey Wiener, Robyn N. Neblett-Fanfair, Athena P. Kourtis, Karen W. Hoover
39 [GO] 2023―Feb―13 Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people living with HIV José L. Casado, Pilar Vizcarra, Sara Martín-Colmenarejo, Judith del Pino, Sandra Gomez-Maldonado, Adrían Martín-Hondarza, Alejandro Vallejo
40 [GO] 2023―Feb―02 Adverse events and SARS-CoV-2 antibody responses after immunization with sputnik V, ChAdOx1-S and BBIBP-CorV vaccines in people with HIV Romina Mauas, Analia Ureña, Diego Cecchini, Maria L. Strada, Soledad Arietti, Isabel Cassetti, et al. (+5)
41 [GO] 2023―Feb―01 The impact of COVID-19 pandemic on the dynamic HIV care engagement among people with HIV: real-world evidence Xueying Yang, Jiajia Zhang, Shujie Chen, Sharon Weissman, Bankole Olatosi, Xiaoming Li
42 [GO] 2023―Jan―25 COVID-19 vaccine immunogenicity in people with HIV: Erratum
43 [GO] 2022―Dec―22 Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Sarah Speckmaier, et al. (+34)
44 [GO] 2022―Dec―21 Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people with HIV Pathum Sookaromdee, Viroj Wiwanitkit
45 [GO] 2022―Dec―08 COVID-19 vaccine immunogenicity in people with HIV Cecilia T. Costiniuk, Joel Singer, Terry Lee, Marc-André Langlois, Corey Arnold, Yannick Galipeau, et al. (+24)
46 [GO] 2022―Dec―08 T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa William C. McMahon, Gaurav Kwatra, Alane Izu, Anthonet L. Koen, Johann Greffrath, Lee Fairlie, et al. (+11)
47 [GO] 2022―Nov―16 Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection Julia Del Amo, Rosa Polo, Santiago Moreno, Esteban Martínez, Alfonso Cabello, José Antonio Iribarren, et al. (+10)
48 [GO] 2022―Oct―18 COVID-19 Vaccine Effectiveness among a Population-based Cohort of People Living with HIV Catharine Chambers, Hasina Samji, Curtis L. Cooper, Cecilia T. Costiniuk, Naveed Z. Janjua, Abigail E. Kroch, et al. (+15)
49 [GO] 2022―Sep―21 Outcomes following SARS-CoV-2 infection among individuals living with and without HIV; a Danish nationwide cohort study Line D. Rasmussen, Susan Cowan, Jan Gerstoft, Gitte Kronborg, Isik S. Johansen, Carsten S. Larsen, et al. (+7)
50 [GO] 2022―Sep―16 The Association between Comorbidities and COVID-19 Hospitalization among People with HIV differs by Age Caitlin A. Moran, Nora T. Oliver, Brittany Szabo, Lauren F. Collins, Minh Ly T. Nguyen, N. Sarita Shah, et al. (+9)
51 [GO] 2022―Sep―02 Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors’ reply Ngai Sze Wong, Bonnie C.K. Wong, Jacky M.C. Chan, Ka Hing Wong, Owen T.Y. Tsang, Shui Shan Lee, Denise P.C. Chan
52 [GO] 2022―Sep―02 Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
53 [GO] 2022―Aug―11 Maternal-foetal transfer of SARS-CoV-2 antibodies among women with and those without HIV infection Marta C. Nunes, Stephanie Jones, Zanele Ditse, Kelly da Silva, Natali Serafin, Renate Strehlau, et al. (+14)
54 [GO] 2022―Jul―25 Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV Frédérique Chammartin, Katharina Kusejko, Chloé Pasin, Alexandra Trkola, Matthias Briel, Patrizia Amico, et al. (+14)
55 [GO] 2022―Jul―22 Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection Michael J. Peluso, Matthew A. Spinelli, Tyler-Marie Deveau, Carrie A. Forman, Sadie E. Munter, Sujata Mathur, et al. (+26)
56 [GO] 2022―Jul―18 Tenofovir disoproxil fumarate and COVID-19 outcomes in men with HIV Guilin Li, Lesley S. Park, Sara Lodi, Roger W. Logan, Emily J. Cartwright, Lydia Aoun Barakat, et al. (+5)
57 [GO] 2022―Jul―18 Impact of the COVID-19 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019-2021 Weiming Zhu, Ya-lin A. Huang, Jeffrey Weiner, Robyn Neblett-Fanfair, Athena P. Kourtis, H. Irene Hall, Karen W. Hoover
58 [GO] 2022―Jul―14 Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV Bezawit A. Woldemeskel, Andrew H. Karaba, Caroline C. Garliss, Evan J. Beck, Tihitina Y. Aytenfisu, Trevor S. Johnston, et al. (+3)
59 [GO] 2022―Jul―14 High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters? Laura Gianserra, Maria Gabriella Donà, Eugenia Giuliani, Christof Stingone, Martina Pontone, Anna Rita Buonomini, et al. (+4)
60 [GO] 2022―Jun―28 Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States Rachel A. Bender Ignacio, Adrienne E. Shapiro, Robin M. Nance, Bridget M. Whitney, Joseph A.C. Delaney, Laura Bamford, et al. (+19)
61 [GO] 2022―Jun―22 Intersecting epidemics: the impact of COVID-19 on the HIV prevention and care continua in the United States Camille E. Spears, Barbara S. Taylor, Albert Y. Liu, Sera M. Levy, Ellen F. Eaton
62 [GO] 2022―Jun―22 Long-lasting adaptive Immune memory specific to SARS-CoV-2 in convalescent COVID-19 Stable People living with HIV Laura Donadeu, Juan Manuel Tiraboschi, Sofía Scévola, Alba Torija, Maria Meneghini, Thomas Jouve, et al. (+10)
63 [GO] 2022―Jun―22 High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated with BNT162b2 Valérie Pourcher, Lisa Belin, Cathia Soulie, Michelle Rosenzwajg, Stéphane Marot, Karine Lacombe, et al. (+12)
64 [GO] 2022―Apr―25 Surrogate neutralisation responses following SARS-CoV-2 vaccination in people living with HIV - comparison between inactivated and mRNA vaccine Ngai Sze Wong, Bonnie C.K. Wong, Jacky M.C. Chan, Ka Hing Wong, Owen T.Y. Tsang, Chris K.P. Mok, et al. (+3)
65 [GO] 2022―Mar―24 Toward demystifying HIV as a risk factor for coronavirus disease 2019 complications Alejandro R. Gener, Shyam Kottilil
66 [GO] 2022―Mar―24 Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV Rocio Montejano, Cristina Marcelo, Iker Falces-Romero, Luis Gonzalez del Valle, Teresa De Soto, Julio Garcia-Rodríguez, Jose R. Arribas
67 [GO] 2022―Feb―24 HIV and SARS-CoV-2 biochemical interactions may not explain clinical outcomes among adults hospitalized with COVID-19 co-infected with HIV: authors’ reply Matthew S. Durstenfeld, Priscilla Y. Hsue
68 [GO] 2022―Jan―27 When pandemics collide: measuring the impact of coronavirus disease 2019 on people with HIV Jeffrey J. Post, Thomas Benfield, Ian Woolley
69 [GO] 2022―Jan―27 High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters? Xinling Xu, Jan Vesterbacka, Soo Aleman, Piotr Nowak
70 [GO] 2022―Jan―11 Impact of COVID-19 epidemics on prevention and care for HIV and other sexually transmitted infections Elisa de Lazzari, Alejandra Martínez-Mimbrero, Iván Chivite, Ana González-Cordón, Maria M. Mosquera, Montserrat Laguno, et al. (+16)
71 [GO] 2022―Jan―11 Impaired antibody response to COVID-19 vaccination in advanced HIV infection Nolan Hassold, Ségolène Brichler, Elise Ouedraogo, Delphine Leclerc, Sophie Carroue, Yamina Gater, et al. (+6)
72 [GO] 2022―Jan―09 Safety and immunogenicity of SARS-CoV-2 mRNA-1273 and BNT162b2 vaccines in people living with HIV Manuel González de Aledo, Angelina Cañizares, Pilar Vázquez-Rodríguez, Ángeles Castro, Luz Moldes, Soledad López, et al. (+3)
73 [GO] 2021―Dec―07 The COVID-19 pandemic and unemployment, 1 subsistence needs and mental health among adults with HIV in the United States Linda Beer, Yunfeng Tie, Sharoda Dasgupta, Tim McManus, Pranesh P. Chowdhury, John Weiser
74 [GO] 2021―Nov―24 SARS-CoV-2 infection and COVID-19 severity in persons with HIV on antiretroviral treatment Julia del Amo, Rosa Polo, Santiago Moreno, Inma Jarrín, Miguel A. Hernán
75 [GO] 2021―Nov―09 Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19 Matthew S. Durstenfeld, Kaiwen Sun, Yifei Ma, Fatima Rodriguez, Eric A. Secemsky, Rushi V. Parikh, Priscilla Y. Hsue
76 [GO] 2021―Nov―01 COVID-19 in Africa: preexisting immunity and HIV Jumari Snyman, Eduard J. Sanders, Thumbi Ndung’u
77 [GO] 2021―Oct―29 Telemedicine and visit completion among people with HIV during the COVID-19 pandemic compared to pre-pandemic Walid G. El-Nahal, Nicola M. Shen, Jeanne C. Keruly, Joyce L. Jones, Anthony T. Fojo, Bryan Lau, et al. (+5)
78 [GO] 2021―Sep―24 SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV Matthew A. Spinelli, Lillian B. Brown, David V. Glidden, Kyle Hunter, Patrick Martin-Tuite, James Zheng, et al. (+4)
79 [GO] 2021―Sep―02 Recognizing and supporting health workers to advance and sustain HIV gains: lessons from PEPFAR programmes during the COVID-19 response Jerilyn R. Hoover, Diana E. Frymus, Temitayo A. Ifafore-Calfee
80 [GO] 2021―Aug―25 Covid-19 hospitalization outcomes in persons with and without HIV in SPAIN Julián Olalla-Sierra, María Dolores Martín-Escalante, Javier García-Alegría, Manuel Rubio-Rivas, Borja de Miguelcampo, María Zurita-Etayo, et al. (+6)
81 [GO] 2021―Aug―25 SARS-CoV-2 antibody prevalence in people with and without HIV in rural western Kenya, January to March 2020 Trevor A. Crowell, Ibrahim I. Daud, Jonah Maswai, John Owuoth, Valentine Sing’oei, Michelle Imbach, et al. (+5)
82 [GO] 2021―Aug―16 An updated meta-analysis on the association between HIV infection and COVID-19 mortality Yadong Wang, Ruo Feng, Jie Xu, Li Shi, Huifen Feng, Haiyan Yang
83 [GO] 2021―Jul―15 Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV Jake A. Ruddy, Brian J. Boyarsky, Justin R. Bailey, Andrew H. Karaba, Jacqueline M. Garonzik-Wang, Dorry L. Segev, et al. (+2)
84 [GO] 2021―Jun―29 False-positive HIV screening test in a patient with pulmonary embolism because of severe acute respiratory syndrome coronavirus 2 infection Aikaterini Papamanoli, George Psevdos
85 [GO] 2021―Jun―27 The challenging of HIV care one year after of COVID-19 pandemic Juliane Cardoso Villela Santos, Juliana Schaia Rocha Orsi, Victoria Stadler Ribeiro, Felipe Francisco Tuon, João Paulo Telles
86 [GO] 2021―May―16 Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV Jake A. Ruddy, Brian J. Boyarsky, William A. Werbel, Justin R. Bailey, Andrew H. Karaba, Jacqueline M. Garonzik-Wang, et al. (+2)
87 [GO] 2021―May―11 Potential reduction in female sex workers’ risk of contracting HIV during Covid-19 Fortunate Machingura, Sungai Chabata, Joanna Busza, Gracious Jamali, Memory Makamba, Jeffrey Dirawo, et al. (+4)
88 [GO] 2021―May―04 Severe coronavirus disease 2019 in a patient with HIV-2 infection Willem J. Wiersinga, Marc van der Valk
89 [GO] 2021―Mar―12 Tenofovir-based PrEP for COVID-19 Colette DeJong, Matthew A. Spinelli, Hideaki Okochi, Monica Gandhi
90 [GO] 2021―Mar―12 Impact of the COVID-19-related global recession on the financing of the global HIV response Caroline A. Bulstra, Ché L. Reddy, Rifat Atun, Till Bärnighausen, Jan A.C. Hontelez
91 [GO] 2021―Feb―26 Risk of adverse COVID-19 outcomes for people living with HIV Maya M. Mellor, Anne C. Bast, Nicholas R. Jones, Nia W. Roberts, José M. Ordóñez-Mena, Alastair J.M. Reith, et al. (+3)
92 [GO] 2020―Dec―30 Lack of RH2 gene expression may have influenced the HIV pandemic in sub-Saharan Africa Kadimo Nthobatsang, Tshimologo Lone Ncenga, Chipo Mwangi-Woto, Tuelo J. Wedu, Tebogo Gabatlhaolwe, Sikhulile Moyo, et al. (+4)
93 [GO] 2020―Dec―10 Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP) Matthew D. Hickey, Elizabeth Imbert, David V. Glidden, Jan Bing Del Rosario, Mary Chong, Angelo Clemenzi-Allen, et al. (+4)
94 [GO] 2020―Dec―01 Changes in HIV preexposure prophylaxis prescribing in Australian clinical services following COVID-19 restrictions Michael W. Traeger, Prital Patel, Rebecca Guy, Margaret E. Hellard, Mark A. Stoové
95 [GO] 2020―Nov―29 Caring for people living with HIV during the global COVID-19 pandemic Olivier Nawej Tshikung, Mikaela Smit, Annalisa Marinosci, Hélène Buvelot, Pablo Valladares, Thanh Do-Co Lecompte, et al. (+2)
96 [GO] 2020―Nov―08 The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the U.S. - applying lessons from high-burden settings Lauren F. Collins, Jonathan A. Colasanti, Minh Ly Nguyen, Caitlin A. Moran, Cecile D. Lahiri, Vince C. Marconi, et al. (+2)
97 [GO] 2020―Sep―09 Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19 Matthew A. Spinelli, Matthew D. Hickey, David V. Glidden, Janet Q. Nguyen, Jon J. Oskarsson, Diane Havlir, Monica Gandhi
98 [GO] 2020―Sep―09 Persons living with HIV may be reluctant to access to COVID-19 testing services Francesco Maria Fusco, Vincenzo Sangiovanni, Claudia Tiberio, Nunzia Papa, Luigi Atripaldi, Vincenzo Esposito
99 [GO] 2020―Aug―31 Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? Antonio Di Biagio, Lucia Taramasso, Chiara Dentone, Antonio Vena, Daniele R. Giacobbe, Andrea De Maria, et al. (+2)
100 [GO] 2020―Aug―13 Factors associated with hospital admission for COVID-19 in HIV patients Antonio Di Biagio, Elena Ricci, Leonardo Calza, Nicola Squillace, Barbara Menzaghi, Stefano Rusconi, et al. (+11)
101 [GO] 2020―Aug―13 Characteristics and outcomes of COVID-19 in patients with HIV Yousaf B. Hadi, Syeda F.Z. Naqvi, Justin T. Kupec, Arif R. Sarwari
102 [GO] 2020―Aug―10 HIV infection and COVID-19 Nicolas Etienne, Marina Karmochkine, Laurence Slama, Juliette Pavie, Dominique Batisse, Rafael Usubillaga, et al. (+10)
103 [GO] 2020―Aug―10 Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV Alexy Inciarte, Ana Gonzalez-Cordon, Jhon Rojas, Berta Torres, Elisa de Lazzari, Lorena de la Mora, et al. (+13)
104 [GO] 2020―Aug―04 Coinfection of severe acute respiratory syndrome coronavirus 2 and HIV in a teaching hospital: still much to learn Lolita Sasset, Eugenia Di Meco, Silvia Cavinato, Anna M. Cattelan
105 [GO] 2020―Aug―04 Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain Estibaliz Molina-Iturritza, Irene San-José-Muñiz, Maite Ganchegui-Aguirre, Leire Balerdi-Sarasola, Zuriñe Ortiz-de-Zárate-Ibarra, Juan C. Gainzarain-Arana, Joseba Portu-Zapirain
106 [GO] 2020―Jul―23 COVID-19 attack rate in HIV-infected patients and in PrEP users Caroline Charre, Vinca Icard, Pierre Pradat, Corinne Brochier, Bruno Lina, Christian Chidiac, Laurent Cotte
107 [GO] 2020―Jul―23 Preserving two decades of healthcare gains for africa in the Covid-19 era Sonak D. Pastakia, Paula Braitstein, Omar Galárraga, Becky Genberg, Jamil Said, Rajesh Vedanthan, et al. (+2)
108 [GO] 2020―Jul―23 Comorbidity Indices in People with HIV and Considerations for COVID-19 Outcomes Alan Winston, Davide De Francesco, Frank Post, Marta Boffito, Jaime Vera, Ian Williams, et al. (+3)
109 [GO] 2020―Jul―16 Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GA Lauren F. Collins, Caitlin A. Moran, Nora T. Oliver, Abeer Moanna, Cecile D. Lahiri, Jonathan A. Colasanti, et al. (+6)
110 [GO] 2020―Jul―16 What one pandemic can teach us in facing another Wafaa M. El-Sadr
111 [GO] 2020―Jun―30 Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV Eric A. Meyerowitz, Arthur Y. Kim, Kevin L. Ard, Nesli Basgoz, Jacqueline T. Chu, Rocio M. Hurtado, et al. (+10)
112 [GO] 2020―Jun―23 Cases of coronavirus disease-2019 in HIV-infected transgender women Eisuke Adachi, Makoto Saito, Kazuhiko Ikeuchi, Tokio Hoshina, Hiroshi Yotsuyanagi
113 [GO] 2020―Jun―03 Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics Nicolas Dauby
114 [GO] 2020―Jun―03 Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV Harry Coleman, Luke B. Snell, Rebecca Simons, Sam T. Douthwaite, Ming J. Lee
115 [GO] 2020―Jun―03 SARS-CoV-2 infection in a highly experienced person living with HIV Simona Di Giambenedetto, Paola Del Giacomo, Arturo Ciccullo, Angelo Porfidia, Giuseppe De Matteis, Rossella Cianci, et al. (+4)
116 [GO] 2020―Apr―19 Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome Junwei Su, Xiaomin Shen, Qin Ni, Hong Zhao, Jieru Cai, Biao Zhu, et al. (+4)
 [1] 

116 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec